313 related articles for article (PubMed ID: 7574048)
1. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
[TBL] [Abstract][Full Text] [Related]
2. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.
Naguib M; Samarkandi AH; Bakhamees HS; Turkistani A; Alharby SW
Br J Anaesth; 1996 Sep; 77(3):424-6. PubMed ID: 8949825
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
[TBL] [Abstract][Full Text] [Related]
4. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients.
Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1992 Oct; 36(7):702-6. PubMed ID: 1441874
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
[TBL] [Abstract][Full Text] [Related]
6. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
[TBL] [Abstract][Full Text] [Related]
7. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
[TBL] [Abstract][Full Text] [Related]
8. [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses].
Blobner M; Busley R; Mann R; Jelen-Esselborn S; Kochs E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct; 34(10):638-41. PubMed ID: 10548961
[TBL] [Abstract][Full Text] [Related]
9. Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade.
Trévien V; Lienhart A; Just B; Chandon M; Baras E; Camatte S
Acta Anaesthesiol Scand Suppl; 1995; 106():66-9. PubMed ID: 8533550
[TBL] [Abstract][Full Text] [Related]
10. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
[TBL] [Abstract][Full Text] [Related]
11. [Effects of different doses of edrophonium antagonism of mivacurium-induced neuromuscular block in the presence of nitrous oxide, propofol, and alfentanil anesthesia].
Ripart J; Drolet P; Perreault L; Girard M
Can J Anaesth; 1996 Apr; 43(4):368-72. PubMed ID: 8697552
[TBL] [Abstract][Full Text] [Related]
12. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.
Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1993 Apr; 37(3):314-8. PubMed ID: 8390770
[TBL] [Abstract][Full Text] [Related]
13. Effect of metoclopramide on mivacurium-induced neuromuscular block.
Motamed C; Kirov K; Combes X; Dhonneur G; Duvaldestin P
Acta Anaesthesiol Scand; 2002 Feb; 46(2):214-6. PubMed ID: 11942874
[TBL] [Abstract][Full Text] [Related]
14. Neostigmine but not edrophonium prolongs the action of mivacurium.
Symington MJ; Mirakhur RK; Kumar N
Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia.
Marcotte J; Drolet P; Perreault L; Girard M
Can J Anaesth; 1995 Oct; 42(10):879-83. PubMed ID: 8706197
[TBL] [Abstract][Full Text] [Related]
16. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
Naguib M; Abdulatif M; al-Ghamdi A
Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
[TBL] [Abstract][Full Text] [Related]
17. Decreased mivacurium requirements and delayed neuromuscular recovery during sevoflurane anesthesia in children and adults.
Bevan JC; Reimer EJ; Smith MF; Scheepers L deV ; Bridge HS; Martin GR; Bevan DR
Anesth Analg; 1998 Oct; 87(4):772-8. PubMed ID: 9768768
[TBL] [Abstract][Full Text] [Related]
18. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
[TBL] [Abstract][Full Text] [Related]
19. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients.
Jan GS; Tong WN; Chan AM; Hui TW; Lo JW
Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671
[TBL] [Abstract][Full Text] [Related]
20. [Neuromuscular and cardiovascular effect of mivacurium in anesthesia induction in patients with renal failure].
Blobner M; Jelen-Esselborn S; Mann R; Kling M; Schneider G; Schneck HJ; Kochs E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):15-21. PubMed ID: 8868527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
